Levosimendan

CSR Synopses following approval of a new medicine or a new indication for an approved medicine in the US or EU. We are making CSR synopses available to supplement the public information available to patients and healthcare providers about the results of our clinical trials and the evidence used to approve a new medicine or a new indication.

{m} Entries

Phase
Study Indication or Disease
Study Name
3001077 AbbVie_IU_icons_outlined_v3 Acutely decompensated heart failure CSR.ORG Survival of Patients with Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomise…
3001069 AbbVie_IU_icons_outlined_v3 Acutely decompensated heart failure CSR.ORG Randomized, Multicenter Evaluation of Intravenous LeVosimendan Efficacy Versus Placebo in the Short Term Treatment of Decompens…